Industry: Consumer Goods
Published Date: 2026-06-14
Pages: 134 Pages
Report ld: 5562855
Request Sample
Customized Report
Mycoprotein Market Size(US$)

CAGR 2026-2032
6.1%
Market Size,2032
USD 1,081
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Mycoprotein market size was US$ 720 million in 2025 and is forecast to reach a readjusted size of US$ 1081 million by 2032 with a CAGR of 6.1% during the forecast period 2026-2032.
Mycoprotein—also known as fungal protein—is produced using edible filamentous fungi or mycelium as the primary biological agent. Through food-grade fermentation processes, substrates such as sugars, grain syrups, starch hydrolysates, or plant-based by-products are converted into protein-rich, high-fiber alternative protein ingredients. These are commonly used in meat analogues, hybrid meat products, plant-based seafood, dairy alternatives, nutritional fortification in baked goods, protein powders, foodservice ingredients, pet food, and certain animal feed formulations. In 2025, global sales volume reached approximately 118,000 metric tons, with an average unit price of around $6,100 per ton and a global capacity utilization rate of approximately 68.5%. Upstream industry players include manufacturers of glucose syrup and starch-based sugars, grain processors, fermentation strain developers, fermentation equipment manufacturers, suppliers of food-grade nutrients and additives, cold-chain packaging companies, and food safety testing agencies. Downstream players comprise plant-based meat brands, frozen food companies, restaurant chains, food ingredient companies, pet food manufacturers, nutritional food brands, retailers, and institutional catering providers; the industry's average gross profit margin is approximately 36.8%. Regarding the cost structure, carbon sources and culture medium raw materials account for approximately 22%, strain maintenance and fermentation nutrients for 7%, fermentation energy consumption and steam for 13%, and equipment depreciation and maintenance for 10%. Labor and factory management account for approximately 9%; dehydration, molding, and texturization for 11%; seasonings, additives, and blended ingredients for 8%; packaging, cold chain, and warehousing/logistics for 10%; testing, quality control, and food safety compliance for 5%; and R&D and other expenses for 5%. The demand list encompasses requirements for plant-based meat bases, whole-cut meat alternatives, fat-reduced blended meat products, plant-based seafood, dairy alternatives, nutritional protein ingredients, pet food proteins, and customized foodservice formulations. Downstream clients include plant-based meat companies, frozen food manufacturers, restaurant chains, ingredient distributors, food processors, pet food manufacturers, nutritional powder brands, retail private-label brands, and institutional catering clients (schools and enterprises). Business opportunities are driven by policies promoting low-carbon food systems, sustainable protein investment, improved food safety regulation, innovation in alternative proteins, and efficient agricultural resource utilization; by technological innovations such as high-yield strain screening, continuous fermentation, low-cost culture media, mycelium structural integrity, dehydration and texturization, flavor masking, and high-protein powder production; and by shifting consumer demands—moving from simple vegetarian substitutes to a comprehensive preference for high-protein, low-fat, and low-cholesterol products that offer authentic meat-like texture, clean labels, and a low carbon footprint, all at price points comparable to conventional meat.
Mycoprotein represents one of the most commercially established segments within the fungal fermentation protein sector, with global sales projected to reach approximately 118,000 tonnes by 2025. Demand is concentrated primarily in Europe and North America; the European market is characterized by mature brands and ingredient-focused production, whereas the North American market is driven by food-tech brands, whole-cut mycelium products, and foodservice trials. Compared to plant-based proteins such as soy and pea protein, mycoprotein’s core advantage lies in the natural fibrous structure of its mycelium, which closely mimics the texture and mouthfeel of meat. Additionally, it offers a nutritional profile rich in protein and dietary fiber while remaining low in fat and cholesterol. Its formulation requires less reliance on extrusion-based texturization and various additives, offering unique value in applications such as meat alternatives, hybrid meat products, functional proteins, and pet food. However, the industry currently faces constraints including high capital investment for fermentation capacity, elevated unit costs, price sensitivity at the retail level, limited consumer awareness regarding fungal-derived proteins, lengthy regulatory approval processes, and high cold-chain logistics costs. Over the next two to five years, industry growth will hinge not merely on expanding the vegetarian consumer base, but on securing acceptance among flexitarians, foodservice providers, and food manufacturers for its use as a stable ingredient. The market is poised for rapid growth if companies can successfully reduce cultivation medium costs, improve fermentation yields, and maximize capacity utilization, while simultaneously expanding product applications beyond premium retail to include B2B ingredients, hybrid meat products, institutional catering, pet food, and nutritional fortification. Overall, the industry remains in a growth phase where leading players currently enjoy a first-mover advantage; however, medium- to long-term competition will shift toward fermentation efficiency, cost control, textural performance, regulatory compliance, and the ability to tailor formulations to specific customer needs.
The global Mycoprotein market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Mycoprotein sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Mycoprotein manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Mycoprotein product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Mycoprotein value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Mycoprotein Product Scope
1.2 Mycoprotein by Type
1.2.1 Global Mycoprotein Sales by Type (2021, 2025 & 2032)
1.2.2 Food Grade Mycoprotein
1.2.3 Feed Grade Mycoprotein
1.3 Mycoprotein by Application
1.3.1 Global Mycoprotein Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Meat Alternatives
1.3.3 Pet Food
1.3.4 Feed
1.4 Global Mycoprotein Market Estimates and Forecasts (2021-2032)
1.4.1 Global Mycoprotein Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Mycoprotein Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Mycoprotein Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Mycoprotein Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Mycoprotein Historical Market Scenario by Region (2021-2026)
2.2.1 Global Mycoprotein Sales Market Share by Region (2021-2026)
2.2.2 Global Mycoprotein Revenue Market Share by Region (2021-2026)
2.3 Global Mycoprotein Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Mycoprotein Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Mycoprotein Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Mycoprotein Market Size and Prospects (2021-2032)
2.4.2 Europe Mycoprotein Market Size and Prospects (2021-2032)
2.4.3 Southeast Asia Mycoprotein Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Mycoprotein Historical Market Review by Type (2021-2026)
3.1.1 Global Mycoprotein Sales by Type (2021-2026)
3.1.2 Global Mycoprotein Revenue by Type (2021-2026)
3.1.3 Global Mycoprotein Average Price by Type (2021-2026)
3.2 Global Mycoprotein Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Mycoprotein Sales Forecast by Type (2027-2032)
3.2.2 Global Mycoprotein Revenue Forecast by Type (2027-2032)
3.2.3 Global Mycoprotein Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Mycoprotein
4 Global Market Size by Application
4.1 Global Mycoprotein Historical Market Review by Application (2021-2026)
4.1.1 Global Mycoprotein Sales by Application (2021-2026)
4.1.2 Global Mycoprotein Revenue by Application (2021-2026)
4.1.3 Global Mycoprotein Average Price by Application (2021-2026)
4.2 Global Mycoprotein Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Mycoprotein Sales Forecast by Application (2027-2032)
4.2.2 Global Mycoprotein Revenue Forecast by Application (2027-2032)
4.2.3 Global Mycoprotein Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Mycoprotein Applications
5 Competition Landscape by Players
5.1 Global Mycoprotein Sales by Player (2021-2026)
5.2 Global Top Mycoprotein Players by Revenue (2021-2026)
5.3 Global Mycoprotein Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Mycoprotein revenue as of 2025
5.4 Global Mycoprotein Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Mycoprotein, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Mycoprotein, Product Type & Application
5.7 Global Key Manufacturers of Mycoprotein, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Mycoprotein Sales by Company
6.1.1.1 North America Mycoprotein Sales by Company (2021-2026)
6.1.1.2 North America Mycoprotein Revenue by Company (2021-2026)
6.1.2 North America Mycoprotein Sales Breakdown by Type (2021-2026)
6.1.3 North America Mycoprotein Sales Breakdown by Application (2021-2026)
6.1.4 North America Mycoprotein Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Mycoprotein Sales by Company
6.2.1.1 Europe Mycoprotein Sales by Company (2021-2026)
6.2.1.2 Europe Mycoprotein Revenue by Company (2021-2026)
6.2.2 Europe Mycoprotein Sales Breakdown by Type (2021-2026)
6.2.3 Europe Mycoprotein Sales Breakdown by Application (2021-2026)
6.2.4 Europe Mycoprotein Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.3.1 Southeast Asia Mycoprotein Sales by Company
6.3.1.1 Southeast Asia Mycoprotein Sales by Company (2021-2026)
6.3.1.2 Southeast Asia Mycoprotein Revenue by Company (2021-2026)
6.3.2 Southeast Asia Mycoprotein Sales Breakdown by Type (2021-2026)
6.3.3 Southeast Asia Mycoprotein Sales Breakdown by Application (2021-2026)
6.3.4 Southeast Asia Mycoprotein Major Customers
6.3.5 Southeast Asia Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Marlow Foods Limited (GB)
7.1.1 Marlow Foods Limited (GB) Company Information
7.1.2 Marlow Foods Limited (GB) Business Overview
7.1.3 Marlow Foods Limited (GB) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Marlow Foods Limited (GB) Mycoprotein Products Offered
7.1.5 Marlow Foods Limited (GB) Recent Development
7.2 ENOUGH (GB)
7.2.1 ENOUGH (GB) Company Information
7.2.2 ENOUGH (GB) Business Overview
7.2.3 ENOUGH (GB) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.2.4 ENOUGH (GB) Mycoprotein Products Offered
7.2.5 ENOUGH (GB) Recent Development
7.3 Meati Foods (US)
7.3.1 Meati Foods (US) Company Information
7.3.2 Meati Foods (US) Business Overview
7.3.3 Meati Foods (US) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Meati Foods (US) Mycoprotein Products Offered
7.3.5 Meati Foods (US) Recent Development
7.4 Nature’s Fynd (US)
7.4.1 Nature’s Fynd (US) Company Information
7.4.2 Nature’s Fynd (US) Business Overview
7.4.3 Nature’s Fynd (US) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Nature’s Fynd (US) Mycoprotein Products Offered
7.4.5 Nature’s Fynd (US) Recent Development
7.5 The Better Meat Co. (US)
7.5.1 The Better Meat Co. (US) Company Information
7.5.2 The Better Meat Co. (US) Business Overview
7.5.3 The Better Meat Co. (US) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.5.4 The Better Meat Co. (US) Mycoprotein Products Offered
7.5.5 The Better Meat Co. (US) Recent Development
7.6 Naplasol (BE)
7.6.1 Naplasol (BE) Company Information
7.6.2 Naplasol (BE) Business Overview
7.6.3 Naplasol (BE) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Naplasol (BE) Mycoprotein Products Offered
7.6.5 Naplasol (BE) Recent Development
7.7 Infinite Roots (DE)
7.7.1 Infinite Roots (DE) Company Information
7.7.2 Infinite Roots (DE) Business Overview
7.7.3 Infinite Roots (DE) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Infinite Roots (DE) Mycoprotein Products Offered
7.7.5 Infinite Roots (DE) Recent Development
7.8 MycoTechnology, Inc. (US)
7.8.1 MycoTechnology, Inc. (US) Company Information
7.8.2 MycoTechnology, Inc. (US) Business Overview
7.8.3 MycoTechnology, Inc. (US) Mycoprotein Sales, Revenue and Gross Margin (2021-2026)
7.8.4 MycoTechnology, Inc. (US) Mycoprotein Products Offered
7.8.5 MycoTechnology, Inc. (US) Recent Development
8 Mycoprotein Manufacturing Cost Analysis
8.1 Mycoprotein Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Mycoprotein
8.4 Mycoprotein Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Mycoprotein Distributors List
9.3 Mycoprotein Customers
10 Mycoprotein Market Dynamics
10.1 Mycoprotein Industry Trends
10.2 Mycoprotein Market Drivers
10.3 Mycoprotein Market Challenges
10.4 Mycoprotein Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Mycoprotein market is projected to grow from US$ 720 million in 2025 to US$ 1081 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-06-14
Pages: 141
USD 4900.00
(Single User License)
The global Mycoprotein market was valued at US$ 720 million in 2025 and is anticipated to reach US$ 1081 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-06-14
Pages: 115
USD 2900.00
(Single User License)
The global market for Mycoprotein was estimated to be worth US$ 720 million in 2025 and is projected to reach US$ 1081 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-06-14
Pages: 130
USD 3950.00
(Single User License)
The global Mycoprotein market size was US$ 414 million in 2024 and is forecast to a readjusted size of US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 72
USD 4250.00
(Single User License)
The global Mycoprotein market is projected to grow from US$ 414 million in 2024 to US$ 910 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 117
USD 4900.00
(Single User License)
In 2024, the global market size of Mycoprotein was estimated to be worth US$ 414 million and is forecast to reach approximately US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 113
USD 5900.00
(Single User License)
The global market for Mycoprotein was estimated to be worth US$ 414 million in 2024 and is forecast to a readjusted size of US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 89
USD 3950.00
(Single User License)
The global market for Mycoprotein was valued at US$ 414 million in the year 2024 and is projected to reach a revised size of US$ 910 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published Date: 2025-01-18
Pages: 75
USD 2900.00
(Single User License)
Mycoprotein is a protein made from Fusarium venenatum, a naturally occurring fungus. To create mycoprotein, manufacturers ferment fungi spores along with glucose and other nutrients. The fermentation process is similar to what’s used to create beer. It results in a doughy mixture with a meat-like texture that’s high in protein and fiber.
Published Date: 2024-01-18
Pages: 84
USD 3950.00
(Single User License)
The global Mycoprotein market is projected to grow from US$ 720 million in 2025 to US$ 1081 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-06-14
Pages: 141
The global Mycoprotein market was valued at US$ 720 million in 2025 and is anticipated to reach US$ 1081 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-06-14
Pages: 115
The global market for Mycoprotein was estimated to be worth US$ 720 million in 2025 and is projected to reach US$ 1081 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-06-14
Pages: 130
The global Mycoprotein market size was US$ 414 million in 2024 and is forecast to a readjusted size of US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 72
The global Mycoprotein market is projected to grow from US$ 414 million in 2024 to US$ 910 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 117
In 2024, the global market size of Mycoprotein was estimated to be worth US$ 414 million and is forecast to reach approximately US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 113
The global market for Mycoprotein was estimated to be worth US$ 414 million in 2024 and is forecast to a readjusted size of US$ 910 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 89
The global market for Mycoprotein was valued at US$ 414 million in the year 2024 and is projected to reach a revised size of US$ 910 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published: 2025-01-18
Pages: 75
Mycoprotein is a protein made from Fusarium venenatum, a naturally occurring fungus. To create mycoprotein, manufacturers ferment fungi spores along with glucose and other nutrients. The fermentation process is similar to what’s used to create beer. It results in a doughy mixture with a meat-like texture that’s high in protein and fiber.
Published: 2024-01-18
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now